Literature DB >> 18554199

Sudden death in a young man with catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation.

Stephen Pizzale1, Michael H Gollob, Robert Gow, David H Birnie.   

Abstract

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a familial condition that presents with exercise-induced syncope or sudden death in children or young adults. In most cases the disease is caused by a mutation in the cardiac ryanodine receptor (RyR2) gene. Current evidence suggests that primary therapy for CPVT is beta blockade and implantable cardioverter defibrillator (ICD) placement. There is a recent report of a patient with CPVT who died despite appropriate ICD therapies, and we report a similar case. Our patient died after probably initially receiving inappropriate ICD shocks for atrial fibrillation. We recommend that utmost efforts should be made to prevent shocks including repeated exercise testing to confirm suppression of PVT.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18554199     DOI: 10.1111/j.1540-8167.2008.01211.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  30 in total

1.  Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia.

Authors:  Hyun Seok Hwang; Can Hasdemir; Derek Laver; Divya Mehra; Kutsal Turhan; Michela Faggioni; Huiyong Yin; Björn C Knollmann
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-01-26

Review 2.  Management of survivors of cardiac arrest - the importance of genetic investigation.

Authors:  Peter J Schwartz; Federica Dagradi
Journal:  Nat Rev Cardiol       Date:  2016-07-07       Impact factor: 32.419

3.  Clinical effectiveness of pulmonary vein isolation for arrhythmic events in a patient with catecholaminergic polymorphic ventricular tachycardia.

Authors:  Naokata Sumitomo; Takahiro Nakamura; Junji Fukuhara; Toshiko Nakai; Ichiro Watanabe; Hideo Mugishima; Masayasu Hiraoka
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

Review 4.  Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia.

Authors:  Michela Faggioni; Dmytro O Kryshtal; Björn C Knollmann
Journal:  Pediatr Cardiol       Date:  2012-03-16       Impact factor: 1.655

5.  Enhanced Cytosolic Ca2+ Activation Underlies a Common Defect of Central Domain Cardiac Ryanodine Receptor Mutations Linked to Arrhythmias.

Authors:  Zhichao Xiao; Wenting Guo; Bo Sun; Donald J Hunt; Jinhong Wei; Yingjie Liu; Yundi Wang; Ruiwu Wang; Peter P Jones; Thomas G Back; S R Wayne Chen
Journal:  J Biol Chem       Date:  2016-10-12       Impact factor: 5.157

6.  Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia.

Authors:  Christian van der Werf; Prince J Kannankeril; Frederic Sacher; Andrew D Krahn; Sami Viskin; Antoine Leenhardt; Wataru Shimizu; Naokata Sumitomo; Frank A Fish; Zahurul A Bhuiyan; Albert R Willems; Maurits J van der Veen; Hiroshi Watanabe; Julien Laborderie; Michel Haïssaguerre; Björn C Knollmann; Arthur A M Wilde
Journal:  J Am Coll Cardiol       Date:  2011-05-31       Impact factor: 24.094

7.  Electrophysiological characteristics of paroxysmal atrial fibrillation originating from superior vena cava: a clinical analysis of 30 cases.

Authors:  Xiang-Min Shi; Hong-Tao Yuan; Hong-Yang Guo; Jian-Ping Guo; Zhao-Liang Shan; Yu-Tang Wang
Journal:  Int J Clin Exp Med       Date:  2015-01-15

8.  Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice.

Authors:  Mihail G Chelu; Satyam Sarma; Subeena Sood; Sufen Wang; Ralph J van Oort; Darlene G Skapura; Na Li; Marco Santonastasi; Frank Ulrich Müller; Wilhelm Schmitz; Ulrich Schotten; Mark E Anderson; Miguel Valderrábano; Dobromir Dobrev; Xander H T Wehrens
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

9.  Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia.

Authors:  Hiroshi Watanabe; Christian van der Werf; Ferran Roses-Noguer; Arnon Adler; Naokata Sumitomo; Christian Veltmann; Raphael Rosso; Zahurul A Bhuiyan; Hennie Bikker; Prince J Kannankeril; Minoru Horie; Tohru Minamino; Sami Viskin; Björn C Knollmann; Jan Till; Arthur A M Wilde
Journal:  Heart Rhythm       Date:  2012-12-31       Impact factor: 6.343

Review 10.  Impact of genetics on the clinical management of channelopathies.

Authors:  Peter J Schwartz; Michael J Ackerman; Alfred L George; Arthur A M Wilde
Journal:  J Am Coll Cardiol       Date:  2013-05-15       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.